HAYWARD, Calif. & CAMBRIDGE, U.K.--(BUSINESS WIRE)--May 16, 2006--Solexa, Inc. (Nasdaq:SLXA - News) today announced that it has been selected for addition to the NASDAQ Biotechnology Index® (Nasdaq:NBI - News) effective Monday, May 22, 2006. Securities included in the NASDAQ Biotechnology Index must be listed on the NASDAQ National Market and be classified according to the FTSE(TM) Global Classification System as either biotechnology or pharmaceutical. Additionally, securities in the index must meet minimum requirements for market value, average daily share volume and seasoning as a public company, among other criteria.
